INVO Bioscience Profit Margin

The latest profit margin for INVO is -122.68% as of June 2026. That compares with -319.37% in the prior-year period — up 61.6% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside INVO Bioscience's historical trend and sector peers before judging valuation or financial health.

Over the past year, INVO's profit margin moved from -319.37% to -122.68% — a 61.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in INVO Bioscience's valuation or profitability profile.

Against Healthcare companies, INVO currently prints -122.68% for profit margin, while the sector average sits near 14.41%. That is roughly 951.0% below the sector mean. Large gaps often invite a closer look at INVO Bioscience's growth, margins, and balance sheet.

Profit Margin shows how effectively INVO Bioscience converts resources into returns. At -122.68%, INVO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -319.37% in the prior-year period — up 61.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting INVO's profit margin (-122.68%), review year-over-year change from -319.37%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.